Millennium Management LLC Increases Stake in Immix Biopharma, Inc.
2026-03-20SEC Filing SCHEDULE 13G (0001104659-26-032741)
Millennium Management LLC, along with Millennium Group Management LLC and Israel A. Englander, has reported acquiring beneficial ownership of Immix Biopharma, Inc. common stock. The filing indicates that as of March 20, 2026, Millennium Management LLC holds 2,812,230 shares, representing 5.3% of the class. This acquisition represents a significant increase from their previous holdings. The joint filing agreement confirms that these entities are acting in concert regarding the ownership and voting of these shares. The filing asserts that the shares were not acquired with the purpose or effect of changing or influencing the control of the issuer.
Related industry:Biotechnology
Source:Original SEC Document β